| Q1 GAAP Revenue | $64.7M | CFO |
| Q1 Revenue YoY Growth | 755% | CFO |
| Q1 Commercial Revenue Mix | ~60% | CFO |
| Q1 International Revenue Mix | ~35% | CFO |
| Q1 Multi-Product Revenue Mix | >1/3 | CFO |
| RPO as of Mar 31, 2026 | $470M | CFO |
| RPO YoY Growth | 554% | CFO |
| Q1 GAAP R&D Expense | $125.7M | CFO |
| Q1 GAAP R&D YoY Growth | 215% | CFO |
| Q1 Adjusted EBITDA Loss | $96.8M | CFO |
| Q1 GAAP Net Income | $805.4M | CFO |
| Cash & Investments as of Mar 31, 2026 | $3.1B | CFO |
| Full Year 2026 Revenue Guidance | $260M - $270M | CFO |
| Full Year 2026 Adjusted EBITDA Guidance | ($310M) - ($330M) | CFO |
| Q2 2026 Revenue Guidance | $65M - $68M | CFO |
| SDA HALO Program Contract Value | $39M | CEO |